SCIENTURE Expands Commercial Reach of REZENOPY™ to Addiction Treatment Centers through an Agreement with a Distribution Partner
Globe Newswire•22/09/2026•08:15 ET
0
Agreement provides dedicated commercial channel for REZENOPY(™) across approximately 2,000 OTP (Opioid Treatment Program) Clinics and other Addiction Treatment Center Networks in the United States
According to IQVIA data (MAT July 2026), the U.S. naloxone market generated approximately $140 million in annual sales across 9.8 million units
Get started
Create a free account to read the full story and Whiz Insights.